Efficacy and safety of anti-TNF alpha therapies in ankilosing spondylitis patients:: 2 years follow-up

被引：0
|
作者：
Erra, A [1 ]
Moreno, E [1 ]
Leon, Y [1 ]
Tomas, C [1 ]
Barceló, P [1 ]
Marsal, S [1 ]
机构：
[1] Univ Barcelona, Hosp Gen Valle Hebron, Barcelona, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：404 / 404
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of anti-TNF alpha therapies in ankylosing spondylitis patients: 54 weeks follow-up
    Erra, A
    Moreno, E
    Guahnon, L
    Tornas, C
    Barcelo, P
    Marsal, S
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 243 - 243
  • [2] ANTI-TNF ALPHA THERAPY IN 12 PATIENTS WITH AA AMYLOIDOSIS: A FOLLOW-UP REPORT OF TOLERANCE AND EFFICACY
    Gottenberg, J-E
    Merle-Vincent, F.
    Berenbaum, F.
    Berthelot, J-M
    Bourgeois, P.
    Combe, B.
    Dougados, M.
    Sibilia, J.
    Vignon, E.
    Mariette, X.
    RHEUMATOLOGY, 2003, 42 : 91 - 92
  • [3] INFLUENCE OF ANTI TNF THERAPIES AND HYPERHOMOCYSTEINEMIA ON BONE MINERAL DENSITY IN ANKILOSING SPONDYLITIS PATIENTS
    Anghel, D.
    Hoinoiu, E. M.
    Negru, M. M.
    Petrache, O. G.
    Costache, N. O.
    Iachim, V.
    Bursuc, R. A.
    Ghiatau, A.
    Manolache, A.
    Smedescu, V. V.
    Plesa, C. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1267 - 1267
  • [4] Efficacy and safety of anti-TNF therapies in rheumatoid arthritis patients in clinical practice: Three years experience
    Moreno, E
    Erra, A
    Guahnon, L
    Tomas, C
    Arnal, C
    Alegre, C
    Barcelo, P
    Marsal, S
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 166 - 166
  • [5] EFFICACY AND SAFETY OF ANTI-TNFα THERAPIES IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL PRACTICE: THREE YEARS EXPERIENCE
    Erra, A.
    Moreno, E.
    Tomas, C.
    Guahnon, L.
    Arnal, C.
    Alegre, C.
    Barcelo, P.
    Marsal, S.
    RHEUMATOLOGY, 2003, 42 : 89 - 89
  • [6] Ultrasonographic assessment of Achilles enthesitis in patients with ankylosing spondylitis: A prospective follow-up under anti-TNF therapy
    Aydin, S.
    Karadag, O.
    Filippucci, E.
    Atagunduz, P.
    Akdogan, A.
    Kalyoncu, U.
    Calguneri, M.
    Direskeneli, H.
    Grassi, W.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 734 - 734
  • [7] Meta-analysis of efficacy of anti-TNF alpha therapy in ankylosing spondylitis patients
    Montilla Salas, Juan
    Munoz Gomariz, Elisa
    Collantesa, Eduardo
    REUMATOLOGIA CLINICA, 2007, 3 (05): : 204 - 212
  • [8] EFFICACY AND SAFETY OF ABATACEPT IN PATIENTS WITH RA AND AN INADEQUATE RESPONSE TO ANTI-TNF THERAPY BY NUMBER OF PRIOR ANTI-TNF THERAPIES USED
    Schiff, M.
    Le Bars, M.
    Gaillez, C.
    Wu, G.
    Poncet, C.
    Genovese, M. C.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S29 - S30
  • [9] ANTI-TNF ALPHA DOSE REDUCTION IN ANKYLOSING SPONDYLITIS PATIENTS
    Ortolan, A.
    Chimenti, M. S.
    Lorenzin, M.
    Frallonardo, P.
    Sunzini, F.
    Conigliaro, P.
    Perricone, R.
    Punzi, L.
    Ramonda, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1128 - 1128
  • [10] Anti-TNFα therapy in 12 patients with AA amyloidosis:: A follow-up report of tolerance and efficacy.
    Gottenberg, JE
    Merle-Vincent, F
    Dougados, M
    Berenbaum, F
    Berthelot, JM
    Combe, B
    Sibilia, J
    Mariette, X
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S71 - S71
12345